The potential impact and optimal cut-points of using glycated haemoglobin, HbA1c, to detect people with impaired glucose regulation in a UK multi-ethnic cohort

被引:45
作者
Mostafa, Samiul A. [1 ]
Khunti, Kamlesh [2 ]
Srinivasan, Balasubramanian Thiagarajan
Webb, David
Gray, Laura J. [2 ]
Davies, Melanie J.
机构
[1] Leicester Royal Infirm, Dept Cardiovasc Sci, Div Diabet & Endocrinol, Leicester LE1 5WW, Leics, England
[2] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England
关键词
Diagnostic criteria; Glycated haemoglobin; Impaired glucose regulation; FASTING GLYCEMIA; A1C; PREVENTION; TOLERANCE; PREVALENCE; DIAGNOSIS; HBA(1C); RISK;
D O I
10.1016/j.diabres.2010.06.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Recommended diagnostic cut-points to detect impaired glucose regulation (IGR, also termed prediabetes impaired fasting glucose and/or impaired glucose tolerance based on WHO 1999 criteria) are HbA1c 6 0-6 4% and 5 7-6 4% from an International Expert Committee and American Diabetes Association, respectively We investigated the impact on prevalence/phenotype from using these criteria compared to IGR detected on oral glucose tolerance testing (OGTT) and determined optimal HbA1c cut-points for IGR in a multi-ethnic cohort Methods Analysis of 8696 participants in the LEADER study of primary care individuals aged 40-75 years without diabetes, in Leicestershire (UK) who underwent OGTT and had HbA1c measured Results Use of OGTT detected less people with IGR (n = 1407, 16 2%) compared to HbA1c 6 06 4% (n = 1610, 18 5%) and HbA1c 5 7-6 4%(n = 3904, 44.9%), a 1 1- and 2 8-fold increase in prevalence, respectively There were 930 (10 7%) and 534 (6 1%) people with IGR on OGTT not detected using HbA1c 6 0-6 4% and 5 7-6 4%, respectively From ROC curve analysis, the optimal cut-point for detecting IGR in white Europeans was HbA1c >= 5 8%, sensitivity/specificity 61 5%/67.9%, but in south Asians HbA1c >= 6 0%, sensitivity/specificity 63 8%/69 4% Conclusion Recommended HbA1c cut-points to detect IGR significantly increase numbers detected, however introduce a change in people identified Using HbA1c 6 0-6 4% lacks sensitivity in white Europeans, but is a reasonable option in south Asians (C) 2010 Elsevier Ireland Ltd All rights reserved
引用
收藏
页码:100 / 108
页数:9
相关论文
共 28 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]  
[Anonymous], 1999, DEF DIAGN CLASS DIAB
[3]   Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups [J].
Brindle, P. ;
May, M. ;
Gill, P. ;
Cappuccio, F. ;
D'Agostino, R., Sr. ;
Fischbacher, C. ;
Ebrahim, S. .
HEART, 2006, 92 (11) :1595-1602
[4]   Screening for type 2 diabetes and impaired glucose metabolism [J].
Colagiuri, S ;
Hussain, Z ;
Zimmet, P ;
Cameron, A ;
Shaw, J .
DIABETES CARE, 2004, 27 (02) :367-371
[5]   Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the US Population in 1988-2006 [J].
Cowie, Catherine C. ;
Rust, Keith F. ;
Byrd-Holt, Danita D. ;
Gregg, Edward W. ;
Ford, Earl S. ;
Geiss, Linda S. ;
Bainbridge, Kathleen E. ;
Fradkin, Judith E. .
DIABETES CARE, 2010, 33 (03) :562-568
[6]  
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE, V26, DOI DOI 10.2337/DIACARE.26.2007.S5
[7]  
Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]
[8]   Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program [J].
Herman, William H. ;
MA, Yong ;
Uwaifo, Gabriel ;
Haffner, Steven ;
Kahn, Steven E. ;
Horton, Edward S. ;
Lachin, John M. ;
Montez, Maria G. ;
Brenneman, Tina ;
Barrett-Connor, Elizabeth .
DIABETES CARE, 2007, 30 (10) :2453-2457
[9]   Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance [J].
Hu, Yaomin ;
Liu, Wei ;
Chen, Yawen ;
Zhang, Ming ;
Wang, Lihua ;
Zhou, Huan ;
Wu, Peihong ;
Teng, Xiangyu ;
Dong, Ying ;
Zhou, Jia Wen ;
Xu, Hua ;
Zheng, Jun ;
Li, Shengxian ;
Tao, Tao ;
Hu, Yumei ;
Jia, Yun .
ACTA DIABETOLOGICA, 2010, 47 (03) :231-236
[10]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403